Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Straus MD

David J. Straus MD

Attending Physician, Lymphoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Dr. David Straus is an attending physician on the Lymphoma Service in the Department of Medicine at Memorial Sloan-Kettering Cancer Center in New York. He has had a large clinical practice for more than 30 years, treating patients with malignant lymphomas, chronic lymphocytic leukemia, and multiple myeloma. His longstanding clinical research interests focus on malignant lymphomas, and he has authored more than 150 publications on this topic. Dr. Straus has conducted clinical trials in Hodgkin’s lymphoma, cutaneous T-cell lymphomas, and HIV-associated lymphomas, as well as studies assessing quality of life and survivorship issues in patients with lymphoma.

Recent Contributions to PracticeUpdate:

  1. ASH 2016: Dr. David Straus's Recommended Abstracts
  2. Nivolumab Results in High Rate of Response in Refractory Classical Hodgkin's Lymphoma
  3. Efficacy of Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma
  4. Ibrutinib Delivers Durable Efficacy in Relapsed/Refractory Mantle Cell Lymphoma
  5. Durable Remissions Achieved With BTK Inhibitor Ibrutinib in Relapsed CLL
  6. Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
  7. Chemotherapy Alone Bests Radiation for Nonbulky Hodgkin's Lymphoma

Most Read This Week

Recently Updated